Consensys, the Ethereum app builder behind MetaMask, has postponed its planned U.S. IPO until at least fall 2026 due to poor market conditions. The company had aimed to file its draft registration with the SEC by February but delayed amid a crypto market downturn and investor caution. Consensys had raised $450 million in 2022, valuing it at $7 billion. This delay reflects broader crypto market volatility, with other firms like Ledger also pausing IPO plans despite improved regulatory clarity in the U.S.
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...
Pomerantz LLP has filed a class action lawsuit against Anavex Life Sciences Corp. following the abrupt firing of its CEO for cause and the company's disclosure of a material weakness in financial controls. The CEO's termination announcement caused a ...
